Clinical Trial Update: Q702 for the Treatment of Patients With Hematologic Malignancies [Phase 1]

View source ↗

Summary

This entry notes a Phase 1 clinical trial (Q702) for hematologic malignancies led by Mayo Clinic, currently recruiting and including histiocytic sarcoma among c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Histiocytic Sarcoma
• Langerhans Cell Histiocytosis
• Myelodysplastic Syndrome
• Myelofibrosis
• Rosai-dorfman-destombes Disease
• Waldenström Macroglobulinemia

Drugs mentioned

• Q702

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphatic System Neoplasm, Histiocytic Sarcoma | Phase 1 | Status: RECRUITING